neurotic excoriation: a condition in which patients produce skin lesions through repetitive, compulsive excoriation of their skin.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
186 |
4. Check minimum number of eventsNone |
186 |
5. Include endpointsNone |
186 |
6. Filter based on genotype QC (FinnGen only) |
186 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L98
- Name in latin
- Dermatitis artificialis
Similar endpoints
↥List of similar endpoints to
Factitial dermatitis
based on the number of shared cases.
Similar with more cases:
- Other disorders of skin and subcutaneous tissue, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1738 | 1165 | 556 |
| Only index persons | 1405 | 982 | 423 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.04 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 54.96 | 55.45 | 53.93 |
| Only index persons | 53.35 | 54.22 | 51.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 186 | 130 | 56 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 48.33 | 47.13 | 51.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 172
- Matched controls
- 1718
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L98.1
ICD-10 Finland
Factitial dermatitis
+∞
172.1
135
*
E0000UV
ATC
NA
6.0
26.4
118
459
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
8.1
24.9
63
115
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
263.7
23.2
23
*
D07AC01
ATC
betamethasone; topical
5.3
23.0
102
373
L30.9
ICD-10 Finland
Dermatitis, unspecified
5.9
21.4
72
188
69840
ICD-8 Finland
Pruritus and related conditions, Dermatitis factitia (artifacta)
+∞
21.3
20
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.8
21.2
45
60
D07AD01
ATC
clobetasol; topical
6.3
20.0
60
134
L28.1
ICD-10 Finland
Prurigo nodularis
112.5
19.0
20
*
D07AC13
ATC
mometasone; topical
4.7
18.9
86
304
6984A
ICD-9 Finland
Pruritus and related conditions, Dermatitis factitia [artifacta][LICHENIFICATIO ET DERMATITIS ARTEFACTA]
+∞
18.0
17
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
7.0
17.8
47
87
L29.9
ICD-10 Finland
Pruritus, unspecified
23.9
16.5
23
11
D09AB01
ATC
zinc bandage without supplements; topical
21.9
16.1
23
12
E000001
ATC
NA
4.6
15.8
64
195
D07AB02
ATC
hydrocortisone butyrate; topical
4.0
15.3
82
320
D07BA04
ATC
hydrocortisone and antiseptics; topical
6.0
14.9
44
93
J01FF01
ATC
clindamycin; systemic
4.1
14.8
73
262
S97
ICPC
Chronic ulcer skin
12.0
14.3
26
25
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.3
14.3
47
113
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.5
13.7
37
69
D07CC01
ATC
betamethasone and antibiotics; topical
5.2
13.4
45
110
D07BC01
ATC
betamethasone and antiseptics; topical
5.7
13.4
41
90
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.3
13.0
42
98
A46
ICD-10 Finland
Erysipelas
5.1
12.7
43
106
D07AA02
ATC
hydrocortisone; topical
4.6
12.5
47
129
N06AX16
ATC
venlafaxine; oral
4.6
12.3
47
131
R06AE07
ATC
cetirizine; oral
3.2
12.1
102
538
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
32.6
11.9
15
5
C03CA01
ATC
furosemide; systemic
3.3
11.1
69
288
N05AH04
ATC
quetiapine; oral
3.9
10.8
50
165
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
64.1
10.8
12
*
J01CF05
ATC
flucloxacillin; systemic
15.6
10.7
17
12
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.8
10.7
31
63
N05CF01
ATC
zopiclone; oral
3.2
10.7
73
322
TQW80
NOMESCO Finland
Local dermatologic skincare
12.4
9.8
17
15
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.7
9.7
22
32
A10AE04
ATC
insulin glargine; parenteral
5.1
9.7
31
71
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
13.4
9.6
16
13
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
+∞
9.5
9
*
D07AB08
ATC
desonide; topical
4.7
9.4
33
83
A06AD11
ATC
lactulose; oral
3.7
9.4
45
151
N05BA04
ATC
oxazepam; oral
3.0
9.3
65
287
N03AX12
ATC
gabapentin; oral
3.9
9.1
39
119
E000002
ATC
NA
4.1
9.1
37
108
N05AA02
ATC
levomepromazine; systemic
7.7
8.8
20
29
J01DB01
ATC
cefalexin; oral
3.6
8.8
151
1145
N03AX16
ATC
pregabalin; oral
3.1
8.7
57
240
103
Kela drug reimbursment
Diabetes, insulin-treated
2.9
8.7
62
276
N06AX21
ATC
duloxetine; oral
4.3
8.7
33
90
R60.0
ICD-10 Finland
Localized oedema
4.4
8.7
32
85
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
6.9
8.6
21
34
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.9
8.6
21
34
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
29.2
8.6
11
*
J01AA07
ATC
tetracycline; systemic
3.5
8.5
42
144
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.9
8.5
28
66
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
94.5
8.5
9
*
SPAT1240
SPAT
Therapeutic discussion
3.9
8.3
35
105
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.2
8.2
25
54
N05BB01
ATC
hydroxyzine; systemic
4.9
8.1
26
60
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
7.6
8.0
18
26
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
7.0
8.0
19
30
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.9
7.9
55
237
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.7
7.9
22
43
SPAT1301
SPAT
No procedures
2.6
7.7
73
381
L30.3
ICD-10 Finland
Infective dermatitis
7.4
7.5
17
25
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
3.7
7.5
33
103
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
7.4
64
314
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
10.0
7.4
14
15
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
10.0
7.4
14
15
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.5
7.4
21
42
M79.6
ICD-10 Finland
Pain in limb
2.5
7.4
76
410
L89
ICD-10 Finland
Decubitus ulcer and pressure area
+∞
7.3
7
*
SPAT1262
SPAT
Handing over of treatment supplies
3.2
7.3
43
164
J01MA02
ATC
ciprofloxacin; systemic
2.5
7.3
77
423
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
31.5
7.2
9
*
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
21.1
7.2
10
5
H02AB06
ATC
prednisolone; systemic
2.4
7.2
91
545
A10AE05
ATC
insulin detemir; parenteral
6.0
7.2
19
35
SPAT1254
SPAT
Administration of medicine
3.3
7.1
38
137
N02AX02
ATC
tramadol; systemic, rectal
2.4
7.0
80
453
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
8.9
7.0
14
17
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.0
6.8
27
77
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
6.7
40
154
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
12.9
6.7
11
9
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.0
6.7
26
73
SPAT1260
SPAT
Consultation of another employee
3.0
6.7
43
174
Z00.8
ICD-10 Finland
Other general examinations
4.6
6.6
22
53
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.9
6.5
26
75
H3603, E103
ICD-10 Finland
NA
15.1
6.5
10
7
L28.2
ICD-10 Finland
Other prurigo
72.4
6.5
7
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
72.4
6.5
7
*
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
72.4
6.5
7
*
A10AA01
ATC
NA
8.7
6.5
13
16
N05AX08
ATC
risperidone; systemic
4.0
6.4
25
70
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
6.4
42
173
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
7.5
6.4
14
20
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
18.9
6.3
9
5
L28.0
ICD-10 Finland
Lichen simplex chronicus
18.9
6.3
9
5
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.1
6.3
24
66
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
6.0
6.2
16
29
S10
ICPC
Boil/carbuncle
6.0
6.2
16
29
A10AA02
ATC
NA
6.5
6.2
15
25
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
10.6
6.1
11
11
N06AX11
ATC
mirtazapine; oral
2.4
6.1
64
343
ZXA00
NOMESCO Finland
Right side
2.5
6.1
57
289
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
3.2
6.1
31
109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
38
54
8.59
26.52
1.6
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
55
140
5.16
21.23
3.1
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
342
2.93
11.03
2.7
2.1
mg/l
3.7
2.9
0.56
67
291
(3024561) Albumin [Mass/volume] in Serum or Plasma
107
616
2.74
10.27
8.6
3.6
g/l
34.4
35.8
1.46
99
577
(3023368) Bacteria identified in Blood by Culture
75
371
2.71
9.59
6.4
3.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
88
479
2.59
9.19
4.3
2.8
u/l
56.8
29.2
0.48
81
457
(3012544) pH of Venous blood
35
127
3.16
7.75
6.3
3.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
48
211
2.72
7.52
3.6
2.0
umol/l
12.5
13.6
0.39
43
188
(3026008) Bacteria identified in Urine by Culture
82
466
2.36
7.43
4.4
2.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
220
2.67
7.35
2.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
46
201
2.71
7.27
3.4
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
39
159
2.84
7.01
15.5
19.1
inr
1.0
1.4
—
10
23
(3019309) Folate [Moles/volume] in Red Blood Cells
56
274
2.49
7.01
1.8
1.7
nmol/l
1405.2
1088.4
1.08
45
203
(3004789) Transferrin [Mass/volume] in Serum or Plasma
43
187
2.69
6.83
3.9
2.0
g/l
2.4
2.4
0.08
37
171
(3006504) Eosinophils/100 leukocytes in Blood
107
704
2.22
6.59
8.4
5.2
%
3.2
2.7
0.57
102
655
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
55
275
2.42
6.52
2.0
1.8
pmol/l
517.8
473.2
0.47
47
230
(3002032) Base excess in Venous blood by calculation
31
116
3.01
6.48
6.5
3.2
mmol/l
2.2
2.2
0.03
25
82
(3022096) Basophils/100 leukocytes in Blood
104
688
2.16
6.18
7.9
5.1
%
0.6
0.7
1.12
99
636
(3001122) Ferritin [Mass/volume] in Serum or Plasma
101
662
2.15
6.13
4.2
2.6
ug/l
108.0
91.9
0.42
91
603
(3000850) Epithelial cells [#/volume] in Urine
58
307
2.29
5.98
2.7
2.5
e6/l
7.0
5.4
0.39
49
276
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
72
419
2.17
5.88
2.7
1.9
u/l
183.6
192.6
0.05
66
397
(3021901) Oxygen saturation in Capillary blood
11
20
5.78
5.88
4.5
2.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
109
747
2.11
5.76
8.6
5.1
e9/l
0.0
0.0
0.09
95
648
(3012516) Albumin [Mass/volume] in Urine
69
401
2.15
5.61
4.7
3.0
mg/l
127.2
221.5
0.23
44
249
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
151
2.62
5.60
2.3
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
76
459
2.11
5.59
4.5
2.4
u/l
42.9
58.5
4.77
69
425
(3013115) Eosinophils [#/volume] in Blood
111
774
2.08
5.51
10.4
5.3
e9/l
0.2
0.2
0.54
99
684
(3019198) Lymphocytes [#/volume] in Blood
110
765
2.07
5.49
8.8
5.1
e9/l
1.8
1.9
0.12
95
683
(3009508) Creatinine [Moles/volume] in Urine
74
445
2.10
5.48
4.6
2.8
mmol/l
6.4
7.5
1.32
60
370
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
38
174
2.49
5.37
3.9
2.1
%
19.5
22.1
0.57
26
147
(3020682) Albumin/Creatinine [Ratio] in Urine
71
425
2.08
5.29
5.7
3.7
mg/mmol
33.8
8.8
0.67
44
258
(3001604) Monocytes [#/volume] in Blood
107
746
2.02
5.20
8.6
5.1
e9/l
0.6
0.6
0.70
95
644
(3005719) IgG [Mass/volume] in Serum or Plasma
26
102
2.80
4.97
4.0
2.2
g/l
8.6
10.6
1.54
21
89
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
103
716
1.98
4.97
12.1
5.8
mmol/l
1.2
1.2
1.75
86
601
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
34
154
2.48
4.90
2.2
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
77
489
1.98
4.78
8.1
4.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
97
667
1.95
4.77
9.5
5.1
mmol/l
1.2
1.2
1.36
88
596
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
100
2.73
4.61
2.0
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
71
446
1.96
4.49
3.3
3.0
e6/l
29.5
207.6
0.66
60
343
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
35
168
2.33
4.44
2.9
2.6
umol/l
6.3
7.7
0.24
29
145
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
49
272
2.09
4.36
4.5
3.0
ng/l
247.9
157.9
0.15
32
197
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
59
351
2.00
4.34
1.5
1.2
u/ml
0.9
1.2
0.20
18
98
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
20
73
2.95
4.34
4.7
3.5
mmol/l
2.0
1.4
0.26
15
52
(3012095) Magnesium [Moles/volume] in Serum or Plasma
42
224
2.13
4.13
3.3
3.0
mmol/l
0.8
0.8
0.12
37
213
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
22
88
2.70
4.05
2.7
3.2
pmol/l
4.4
4.6
0.22
17
77
(40768797) Stomach Pathology biopsy report
39
205
2.14
3.97
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
76
505
1.85
3.96
3.4
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
106
784
1.82
3.87
7.5
5.6
umol/l
9.8
10.3
0.27
100
743
(3028707) Methadone [Presence] in Urine by Screen method
11
29
3.97
3.86
2.3
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
76
509
1.83
3.84
3.6
2.9
mmol/l
2.3
2.4
0.84
58
444
(3013707) Erythrocyte sedimentation rate by Westergren method
140
1133
1.95
3.79
5.7
4.0
mm/h
15.8
11.8
2.13
129
1045
(3023520) Reticulocytes [#/volume] in Blood
24
104
2.50
3.78
3.7
2.6
e9/l
74.3
70.3
0.16
19
84
(40760892) CBC W Ordered Manual Differential panel - Blood
55
337
1.90
3.64
4.6
4.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
133
2.30
3.62
4.0
3.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
87
2.59
3.62
8.9
3.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
142
1163
1.93
3.60
5.5
3.8
pmol/l
14.5
14.7
0.36
128
1055
(3007164) IgA [Mass/volume] in Serum or Plasma
51
306
1.92
3.59
1.9
1.3
g/l
2.4
2.2
0.35
34
180
(3026782) Osmolality of Urine
48
285
1.92
3.48
2.5
2.6
mosm/kgh2o
519.5
566.6
0.65
42
249
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
89
642
1.74
3.39
2.8
2.2
nmol/l
74.5
76.9
0.36
83
568
(3032080) INR in Blood by Coagulation assay
81
571
1.74
3.34
10.1
6.8
inr
1.2
1.2
0.47
25
164
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
174
2.09
3.31
1.8
1.6
%
1.5
1.4
0.23
23
151
(3013650) Neutrophils [#/volume] in Blood by Automated count
113
876
1.74
3.29
14.2
8.7
e9/l
4.4
4.1
0.56
104
768
(3000494) Fungus identified in Specimen by Culture
33
177
2.05
3.17
1.8
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
20
4.67
3.15
1.3
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
39
3.22
3.15
2.7
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
62
411
1.76
3.13
3.0
2.9
e6/l
0.2
0.4
1.48
45
308
(3003396) Base excess in Arterial blood by calculation
30
156
2.10
3.12
8.7
5.5
mmol/l
2.1
1.0
0.66
23
121
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
63
420
1.76
3.12
3.2
2.7
ng/l
3145.9
1191.1
0.43
54
352
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
16
5.17
3.08
1.0
1.6
nmol/l
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
82
590
1.70
3.08
2.1
1.9
pmol/l
92.9
96.7
0.36
46
298
(3022313) Gas panel - Capillary blood
14
51
2.89
3.06
6.0
4.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
21
4.45
3.03
1.4
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
16
64
2.64
2.96
7.8
2.3
mmol/l
25.2
24.2
0.80
16
64
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
50
316
1.80
2.95
1.8
1.7
mg/l
0.8
1.1
0.93
33
252
(3020779) Urea [Moles/volume] in Serum or Plasma
22
103
2.29
2.94
17.0
5.7
mmol/l
13.9
8.2
1.74
22
95
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
22
4.24
2.92
2.6
2.3
%
60.1
57.5
—
9
22
(3037467) Urinalysis macro (dipstick) panel - Urine
128
1046
1.72
2.91
6.5
4.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
13
5.55
2.89
1.0
1.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
9
6.84
2.89
3.5
3.4
nmol/l
162.0
107.0
—
6
9
(3000991) Gas panel - Venous blood
23
111
2.22
2.87
5.8
6.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
56
369
1.74
2.86
2.9
2.5
umol/l
11405.8
8047.1
0.11
46
308
(3004588) Protein electrophoresis panel - Serum or Plasma
20
91
2.34
2.85
2.0
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
66
457
1.69
2.81
6.1
3.7
ph
7.4
7.4
0.08
16
83
(3035637) Corticotropin [Mass/volume] in Plasma
7
14
5.15
2.75
1.1
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
170
1528
2.31
2.71
31.7
14.0
mmol/l
4.0
4.0
0.58
164
1479
(21494755) Public health laboratory ask at order entry panel
5
162
0.29
2.56
1.4
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
11
39
2.93
2.52
3.4
4.1
mg/l
1.9
1.4
0.89
11
34
(3028300) Cannabinoids [Presence] in Urine
14
57
2.57
2.51
2.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
57
2.57
2.51
2.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
57
2.57
2.51
2.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
16
4.50
2.50
2.0
2.7
—
—
—
0
0
(4062490)
7
16
4.50
2.50
1.0
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
74
542
1.61
2.48
4.3
3.6
e6/l
54.9
62.1
0.12
61
372
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
58
2.53
2.43
2.5
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
58
2.53
2.43
2.2
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
40
2.86
2.42
1.1
1.0
—
0.9
—
0
7
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
22
3.75
2.39
2.8
2.1
e9/l
4.1
4.8
—
8
22
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
138
1178
1.66
2.38
11.5
6.7
u/l
89.0
78.1
1.71
131
1094
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
59
413
1.63
2.35
2.2
1.6
mmol/l
1.6
1.4
0.43
47
360
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
90
697
1.56
2.34
6.4
3.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
23
3.59
2.29
6.4
2.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
52
356
1.64
2.26
2.8
2.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
42
272
1.70
2.24
2.8
2.6
mmol/l
2.4
2.4
0.08
34
238
(3044242) Glucose [Moles/volume] in Arterial blood
5
9
5.67
2.22
3.8
1.9
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
9
5.67
2.22
8.8
7.7
mmol/l
0.5
0.6
—
5
9
(3037522) Nuclear Ab [Titer] in Serum
33
200
1.79
2.21
1.5
1.4
titre
173.3
470.9
—
6
53
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
74
555
1.55
2.18
4.4
3.5
ng/l
77.3
41.8
0.56
46
370
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
158
1410
1.80
2.18
6.9
4.6
mu/l
1.9
1.9
0.26
146
1283
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
30
3.10
2.18
1.3
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
55
2.47
2.17
2.3
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
49
2.55
2.15
2.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
43
2.66
2.14
3.6
3.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
167
1519
1.97
2.12
30.0
12.3
mg/l
24.3
22.2
0.40
145
1185
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
179
1.81
2.12
1.9
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
31
3.00
2.10
2.4
1.5
—
—
—
0
0
(4306422)
7
20
3.59
2.07
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
64
473
1.54
1.99
3.0
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
16
3.84
1.95
1.0
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
47
325
1.60
1.94
5.4
4.0
kg/l
1.0
1.0
—
7
46
(36660697) Celiac disease serology panel - Serum
22
124
1.88
1.85
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
12
4.25
1.83
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
12
4.25
1.83
1.8
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
23
3.12
1.81
1.3
2.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
30
2.74
1.74
5.8
2.7
kpa
5.4
5.1
—
8
30
(3027315) Oxygen [Partial pressure] in Blood
8
30
2.74
1.74
5.8
2.7
kpa
8.9
9.0
—
8
30
(3021960) Folate [Moles/volume] in Serum or Plasma
49
352
1.53
1.71
1.6
1.5
nmol/l
23.8
21.8
0.27
42
293
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
83
2.02
1.70
4.4
5.1
mmol/l
25.9
24.6
0.79
16
83
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
31
2.65
1.68
1.6
1.5
—
—
—
0
0
(3015736) pH of Urine
73
574
1.45
1.63
4.6
3.5
—
—
—
0
0
(3013512) EKG study
55
409
1.49
1.63
3.7
3.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
107
1.86
1.62
1.3
1.2
iu/ml
273.1
161.3
—
5
41
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
141
0.41
1.60
3.2
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
20
115
1.83
1.60
4.3
3.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
57
2.18
1.59
5.0
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
39
271
1.56
1.57
1.2
1.3
iu/ml
12.3
28.6
2.17
11
95
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
15
3.39
1.53
1.6
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
45
2.29
1.49
1.6
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
118
1024
1.42
1.47
4.7
3.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
54
408
1.46
1.46
3.1
2.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
22
2.78
1.44
2.3
1.5
%
92.6
90.7
—
6
22
(3020891) Body temperature
11
53
2.14
1.41
9.1
4.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
118
1029
1.40
1.39
5.5
2.9
u/l
62.3
45.1
0.75
111
965
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
17
2.99
1.36
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
17
2.99
1.36
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
18
2.82
1.29
1.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
35
2.34
1.28
1.6
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
25
2.45
1.25
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
25
2.45
1.25
1.5
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
25
2.45
1.25
1.3
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
152
1398
1.48
1.24
25.9
13.3
%
39.6
39.9
0.20
90
1055
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
242
1.50
1.23
2.0
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
51
394
1.41
1.21
5.4
3.9
estimate
0.0
0.0
0.00
19
132
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
80
1.81
1.16
2.3
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
65
1.90
1.16
9.2
6.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
20
2.54
1.16
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
20
2.54
1.16
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
20
2.54
1.16
1.0
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
88
749
1.33
1.13
4.8
3.7
estimate
0.0
0.0
0.00
16
130
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.42
1.09
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.42
1.09
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
21
2.42
1.09
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
32
2.23
1.09
3.4
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
35
2.04
1.01
2.3
2.0
g/l
132.4
129.7
—
7
21
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
35
2.04
1.01
1.6
1.1
—
—
—
0
0
(3019225) pH of Specimen
21
141
1.55
1.00
11.5
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
86
740
1.30
0.99
6.9
5.1
estimate
0.0
0.0
0.00
20
134
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
23
2.21
0.98
2.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
73
615
1.31
0.98
2.2
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
27
2.26
0.94
2.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
37
283
1.38
0.93
2.1
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
67
562
1.30
0.92
5.6
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
119
1.57
0.92
2.6
2.9
ml/min/173m2
66.2
64.2
—
5
51
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
29
2.10
0.90
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
56
1.83
0.89
5.5
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
30
2.03
0.87
2.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
31
1.97
0.85
1.7
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
261
1.37
0.84
1.3
1.3
u/ml
32.8
12.3
0.49
12
102
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
30
226
1.39
0.83
2.6
2.7
e6/l
4.5
2.7
0.46
17
118
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
150
0.58
0.83
1.4
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
115
1.53
0.80
3.9
3.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
84
736
1.26
0.80
5.3
3.7
estimate
0.0
0.0
0.00
19
137
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
75
651
1.25
0.76
17.0
8.7
e9/l
0.0
0.0
0.91
65
518
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
9
53
1.73
0.76
1.4
1.4
g/l
0.2
0.2
—
9
53
(3011397) Hemoglobin [Presence] in Urine by Test strip
42
339
1.31
0.76
4.5
3.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
148
1391
1.31
0.75
9.2
5.2
mmol/mol
45.7
39.2
5.37
140
1299
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
24
2.11
0.75
1.2
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
24
2.11
0.75
1.4
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
56
1.64
0.73
1.4
1.4
g/l
1.2
1.2
—
9
56
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
26
1.95
0.71
2.6
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
26
1.95
0.71
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
26
1.95
0.71
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
49
408
1.27
0.70
4.5
3.2
—
—
—
0
0
(3000492) Spirometry study
19
136
1.44
0.70
1.3
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
61
1.68
0.70
4.4
2.8
%
58.3
49.9
—
10
61
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
91
0.54
0.69
2.0
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
27
1.87
0.69
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
42
505
0.78
0.68
3.5
2.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
181
1.37
0.67
11.0
7.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
103
1.50
0.67
1.5
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
5
28
1.81
0.66
2.6
1.5
mmol/l
1.3
1.6
—
5
28
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
72
1.56
0.60
3.2
2.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
239
1.30
0.60
2.7
2.5
e6/l
0.9
0.9
0.03
16
130
(40758558) Short blood count panel - Blood
46
388
1.25
0.59
12.4
7.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
97
0.61
0.53
2.0
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
180
1.32
0.53
1.2
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
40
1.52
0.52
3.3
4.5
—
4.2
—
0
5
(3026361) Erythrocytes [#/volume] in Blood
173
1687
1.36
0.44
40.6
18.6
e12/l
4.4
4.5
0.83
168
1639
(3010813) Leukocytes [#/volume] in Blood
173
1687
1.36
0.44
40.8
18.7
e9/l
7.0
6.6
2.03
168
1639
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
56
1.45
0.43
1.5
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
27
223
1.25
0.43
3.3
3.9
%
23.3
21.2
0.23
13
100
(4035726)
17
132
1.32
0.42
1.6
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
16
0.00
0.41
0.0
1.4
—
343.0
—
0
16
(40768806) Pleura Pathology biopsy report
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
17
133
1.31
0.40
5.1
4.7
mmol/l
1.3
1.4
0.12
17
128
(3003434) Protein [Mass/volume] in Pleural fluid
0
19
0.00
0.39
0.0
1.4
—
29.9
—
0
19
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
166
1615
1.26
0.39
16.6
9.6
u/l
31.4
25.2
0.54
158
1558
(3002256) Pathology report gross observation
23
190
1.24
0.37
1.3
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
6
41
1.48
0.36
3.3
4.4
mg/l
26.0
28.9
—
6
33
(3034860) Kappa light chains.free [Mass/volume] in Serum
6
41
1.48
0.36
3.5
4.4
mg/l
25.3
45.3
—
6
33
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
275
1.20
0.36
1.5
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
43
1.41
0.35
2.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
43
1.41
0.35
1.2
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
73
1.39
0.35
3.4
2.1
%
1.4
1.2
—
10
73
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
88
0.67
0.34
1.7
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
46
1.31
0.33
1.3
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
52
1.36
0.31
1.9
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
151
1468
1.15
0.28
5.4
4.3
mmol/l
6.6
5.9
3.39
135
1339
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
103
980
1.11
0.27
3.5
3.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
162
1585
1.17
0.25
25.1
11.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
2.2
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
41
1.23
0.22
1.4
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.2
—
16.8
—
0
11
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.3
—
7558.0
—
0
5
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(4024509)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
99
1.23
0.20
1.5
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
145
1416
1.11
0.19
23.7
11.7
ml/min/173m2
80.7
82.0
0.23
121
1146
(3002385) Erythrocyte distribution width [Ratio]
131
1274
1.10
0.19
32.6
15.6
%
14.1
13.7
1.33
125
1256
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
6
52
1.16
0.19
1.0
1.5
—
313.9
—
0
31
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
53
1.14
0.19
1.7
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
53
1.14
0.19
1.7
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
53
1.14
0.19
1.7
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
91
1.22
0.18
1.3
1.3
—
37.3
—
0
6
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
61
1.15
0.18
1.9
2.2
u/l
26.0
40.5
—
7
55
(3045414) Leukocytes [Presence] in Urine
5
69
0.72
0.17
1.4
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
79
1.15
0.15
3.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
150
0.86
0.15
1.6
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
82
1.10
0.15
2.0
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
161
1.13
0.13
1.7
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
39
414
0.93
0.12
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
291
0.92
0.12
1.4
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
149
1512
0.93
0.11
5.6
4.7
mmol/l
2.7
2.8
0.48
133
1398
(4034850)
5
47
1.07
0.09
6.6
7.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
175
0.91
0.09
1.2
2.2
—
—
—
0
0
(4010399)
10
112
0.89
0.07
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
147
1486
0.95
0.07
5.5
4.2
mmol/l
4.6
4.7
0.57
131
1377
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
86
1.05
0.07
1.1
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
102
1.08
0.03
2.3
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
104
1.06
0.01
4.0
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
159
1.01
0.00
1.2
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
142
1424
0.99
0.00
4.8
3.7
mmol/l
1.4
1.3
1.42
121
1304
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
147
1475
0.98
0.00
5.0
4.2
mmol/l
1.5
1.5
0.85
130
1361
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
95
1.06
0.00
1.0
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
11
105
1.05
0.00
2.6
2.4
—
16.1
—
0
7
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
4.0
—
51.8
—
0
6
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
60
1.00
0.00
3.8
3.0
u/ml
6863.2
2285.3
—
6
53
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
5.5
—
98.8
—
0
6
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
11.0
—
0
5
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
72
0.97
0.00
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.0
—
209.9
—
0
7
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
15.5
—
0
6
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
23.6
—
0
5
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
13.6
—
0
5
(40768793) Breast Pathology biopsy report
5
59
0.84
0.00
1.2
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.4
—
13.4
—
0
9
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_FACTITIALDERMAT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_FACTITIALDERMAT | 1.852 [1.48, 2.32] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.356 |
During the follow-up period (1.1.1998 — 31.12.2019), 235 out of 821 females with L12_FACTITIALDERMAT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_FACTITIALDERMAT | 2.697 [1.9, 3.82] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 141 out of 347 males with L12_FACTITIALDERMAT died.
Mortality risk
Mortality risk for people of age
years, who have L12_FACTITIALDERMAT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.189% | 0.509% |
| 5 | 1.244% | 2.861% |
| 10 | 2.935% | 7.543% |
| 15 | 5.525% | 13.919% |
| 20 | 9.486% | 24.042% |
Relationships between endpoints
↥Index endpoint: L12_FACTITIALDERMAT – Factitial dermatitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data